Does AMISULPRIDE Cause Salivary hypersecretion? 69 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Salivary hypersecretion have been filed in association with AMISULPRIDE (Barhemsys). This represents 2.2% of all adverse event reports for AMISULPRIDE.
69
Reports of Salivary hypersecretion with AMISULPRIDE
2.2%
of all AMISULPRIDE reports
4
Deaths
41
Hospitalizations
How Dangerous Is Salivary hypersecretion From AMISULPRIDE?
Of the 69 reports, 4 (5.8%) resulted in death, 41 (59.4%) required hospitalization, and 4 (5.8%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Therapeutic product effect incomplete (200)
Off label use (191)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which AMISULPRIDE Alternatives Have Lower Salivary hypersecretion Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE